지금 시작
ABBVIE INC CEDEAR EACH 10 REPR 1 COMABBVIE INC CEDEAR EACH 10 REPR 1 COMABBVIE INC CEDEAR EACH 10 REPR 1 COM

ABBVIE INC CEDEAR EACH 10 REPR 1 COM

거래 없음
슈퍼차트에서 보기
오버뷰 파이낸셜 뉴스 토론 테크니컬즈 시즌별
채권

ABBV 채권

아래는 ABBVIE INC CEDEAR EACH 10 REPR 1 COM 회사채 목록입니다. 투자자들은 시장 변동성이 큰 시기에 안정성을 높이기 위해 회사채를 선택하는 경우가 많습니다. 가격, 수익률 및 기타 통계를 살펴보고 신뢰할 수 있는 투자처를 찾아보세요.
심볼
YTM %
거래량
가격 %
쿠폰 %
머튜어리티 데이트
미결제 금액
액면가
최소 액면 금액
발행자
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
6.90%60 K76.07%4.85%2044-06-1565.232 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
6.87%20 K75.07%4.63%2042-10-0167.493 M USD1,000.00 USD2,000.00 USDActavis, Inc.
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
6.44%10 K79.20%4.75%2045-03-1553.51 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
5.75%64 K90.42%4.55%2035-03-15107.646 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
5.70%50 K89.00%3.20%2029-11-2162.515 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
5.39%9.14 M102.13%5.50%2064-03-151.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
5.37%50 K90.96%4.63%2042-10-01389.217 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
5.28%5.001 M102.01%5.40%2054-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
5.27%3.485 M94.16%4.88%2048-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABBABBVIE 15/45
5.27%092.46%4.70%2045-05-142.7 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
5.24%100 K94.89%4.85%2044-06-151.008 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
5.24%1.904 M93.52%4.75%2045-03-15827.091 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAW9ABBVIE 16/46
5.23%089.20%4.45%2046-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
5.22%3.058 M101.61%5.35%2044-03-15750 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042
5.17%664 K90.59%4.40%2042-11-062.599 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
5.16%45.18 M86.10%4.25%2049-11-215.745 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
5.07%4.432 M88.93%4.05%2039-11-214 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAV1ABBVIE 16/36
4.99%093.79%4.30%2036-05-141 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAR0ABBVIE 15/35
4.94%096.30%4.50%2035-05-142.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
4.92%1.336 M96.91%4.55%2035-03-151.681 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
4.87%6.068 M101.33%5.05%2034-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
AA5QDALLERGAN FNDG 15/25
4.75%099.07%3.80%2025-03-15130.225 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
4.74%096.53%2.95%2026-11-219.245 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
4.72%2.691 M101.25%4.95%2031-03-152 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
4.60%17.678 M93.69%3.20%2029-11-215.437 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
4.59%12.317 M100.82%4.80%2029-03-152.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAY5ABBVIE 16/26
4.49%098.12%3.20%2026-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
4.47%12.487 M100.74%4.80%2027-03-152.25 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
4.46%2.126 M97.07%2.95%2026-11-213.991 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
4.39%6.965 M99.47%4.25%2028-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABCABBVIE 15/25
4.30%099.31%3.60%2025-05-143.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5083839AbbVie Inc. 3.8% 15-MAR-2025
4.20%3.424 M99.61%3.80%2025-03-152.889 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XS190919331ALLERGAN FNDG 18/28
3.85%095.43%2.63%2028-11-1572.107 M EUR1,000.00 EUR100,000.00 EURAllergan Funding SCS
XXS162262122ALLERGAN FNDG 17/29
3.82%092.90%2.13%2029-06-0136.462 M EUR1,000.00 EUR100,000.00 EURAllergan Funding SCS
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
3.07%0121.31%4.25%2049-11-214.95 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
3.03%0126.76%4.75%2045-03-155 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
2.96%0128.71%4.85%2044-06-15100 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABGABBVIE 19/31
2.92%089.36%1.25%2031-11-18650 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
XS212591491ABBVIE 20/29
2.81%097.07%2.13%2029-06-01506.088 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
XS212591483ABBVIE 20/28
2.77%099.44%2.63%2028-11-15427.793 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
XS152090781ABBVIE 16/28
2.71%097.76%2.13%2028-11-17750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
ABBV5066461AbbVie Inc. 2.6% 21-NOV-2024
2.68%8.305 M99.92%2.60%2024-11-213.739 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABEABBVIE 19/27
2.60%094.62%0.75%2027-11-18750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2.02%0123.74%4.55%2035-03-151 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4997740AbbVie Inc. 3.8% 15-MAR-2025
1.63%0102.15%3.80%2025-03-151.268 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911714AbbVie Inc. 2.6% 21-NOV-2024
−3.63%0106.34%2.60%2024-11-2110.86 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5067241AbbVie Inc. 3.8% 15-MAR-2025
———3.80%2025-03-15—1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
———4.40%2042-11-061.1 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.